Nasr R.; Guillemin M.-C.; Ferhi O.; Soilihi H.; Peres L.; Berthier C.; Rousselot P.; Robledo-Sarmiento M.; Lallemand-Breitenbach V.; Gourmel B.; Vitoux D.; Pandolfi P.P.; Rochette-Egly C.; Zhu J.; De The H.
(, 2008)
Retinoic acid and arsenic trioxide target the protein stability and transcriptional repression activity of the fusion oncoprotein PML-RARA, resulting in regression of acute promyelocytic leukemia (APL). Phenotypically, ...